RAXONE
Live / Registered — Registered (as of 26 Sept 2023)
What this means for you
Registered since 26 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97407005
- Registration number
- 7172934
- Mark type
- Stylized text
- Filed
- 12 May 2022
- Published for opposition
- 11 Jul 2023
- Registered
- 26 Sept 2023
- Attorney of record
- Patrick J. Concannon
Goods and services
- Class 001 — Chemicals: chemicals used in industry and science
- Class 005 — Pharmaceuticals: pharmaceutical, veterinary and sanitary preparations, namely, chemical preparations for use in the treatment of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss
- Class 042 — Scientific and technological services: computer programming for scientific and industrial research in the fields of cell cultures, muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss; scientific re-search for cellular test systems that evaluate drugs and antibodies; scientific research for finding pharmacologically active compounds and animal models for neuromuscular diseases, scientific research in the fields of muscular dystrophy, muscle wasting, atrophy, neuromuscular diseases, cardiomyopathies, ataxias, optic nerve degradation, neurological indications and memory loss
Owner
- CHIESI FARMACEUTICI S.P.A., PARMA, IT
- Santhera Pharmaceuticals (Schweiz) AG, Pratteln, CH
- Santhera Pharmaceuticals (Schweiz) AG, Pratteln, CH
- Santhera Pharmaceuticals (Schweiz) AG, Pratteln, CH
Prosecution history
- 04 Oct 2023 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 26 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 26 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 11 Jul 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 11 Jul 2023 — PUBLISHED FOR OPPOSITION
- 21 Jun 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 02 Jun 2023 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 26 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 May 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 02 Mar 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Mar 2023 — NON-FINAL ACTION E-MAILED
- 02 Mar 2023 — NON-FINAL ACTION WRITTEN
- 02 Mar 2023 — ASSIGNED TO EXAMINER